2-羟基丙酰肼 | 2651-42-5

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: 2-羟基丙酰肼
• 英文名称: N-amino-2-hydroxypropanamide
• 英文别名: lactoylhydrazine；Lactohydrazid；DL-lactic acid hydrazide；2-hydroxy-propionic acid hydrazide；lactic acid hydrazide；Milchsaeure-hydrazid；Lacthydrazide；2-hydroxypropanehydrazide
• CAS: 2651-42-5
• 化学式: C₃H₈N₂O₂
• mdl: MFCD00038134
• 分子量: 104.109
• InChiKey: QCICYPQPGJJZGW-UHFFFAOYSA-N

物化性质

• 沸点：
  153-156 °C(Press: 2 Torr)
• 密度：
  1.216±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -1.5
• 重原子数：
  7
• 可旋转键数：
  1
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.666
• 拓扑面积：
  75.4
• 氢给体数：
  3
• 氢受体数：
  3

安全信息

• 海关编码：
  2928000090

反应信息

• 作为反应物：
  描述：

  2-羟基丙酰肼 生成 alkaline earth salt of/the/ methylsulfuric acid
  参考文献：
  名称：

  Curtius, Journal fur praktische Chemie (Leipzig 1954), 1917, vol. <2> 95, p. 211

  摘要：

  DOI：
• 作为产物：
  描述：

  乳酸甲酯 在 一水合肼 作用下， 以 盐酸 、 乙醇 为溶剂， 生成 2-羟基丙酰肼
  参考文献：
  名称：

  Indazole compounds, compositions thereof and methods of treatment therewith

  摘要：

  这项发明通常涉及使用吲唑化合物来治疗或预防与蛋白激酶相关的疾病，包括酪氨酸激酶，诸如增殖性疾病、炎症性疾病、异常血管生成及其相关疾病、动脉硬化、黄斑变性、糖尿病、肥胖、疼痛等。这些方法包括向有需要的患者施用有效量的吲唑化合物，以抑制、调节或控制酪氨酸激酶信号转导。本文中提供了一种新型的吲唑化合物或其药用可接受的盐。

  公开号：

  US20050009876A1

文献信息

• Methods for treating an inflammatory condition or inhibiting JNK
  申请人：——

  公开号：US20040127536A1

  公开（公告）日：2004-07-01

  This invention is generally directed to Indazole Derivatives having the following structure: 1 or pharmaceutically acceptable salt thereof, wherein R 1 , R 2 and A are as defined herein. Such compounds have utility in the treatment of a wide range of diseases and disorders that are responsive to JNK inhibition, such as an inflammatory disease or disorder. Thus, methods of treating such diseases and disorders are also disclosed, as are pharmaceutical compositions containing one or more compounds of the above compounds.

  这项发明通常涉及吲唑衍生物，具有以下结构： 1 或药用可接受的盐，其中R 1 ，R 2 和A如本文所述定义。这类化合物在治疗对JNK抑制剂有响应的广泛疾病和障碍，如炎症性疾病或障碍中具有用途。因此，还披露了治疗这些疾病和障碍的方法，以及包含一个或多个上述化合物的药物组合物。
• Preparation and Thermolysis of<i>N</i>-Ammonioamidates Containing Hydroxyl Group in Acyl Moiety
  作者：Araki Masuyama、Kikuo Tsuchiya、Mitsuo Okahara

  DOI：10.1246/bcsj.58.2855

  日期：1985.10

  The title N-ammonioamidates (aminimides) were prepared in satisfactory yields from lactones or α-hydroxy carboxylates. By the thermolysis of these aminimides in mesitylene, some types of urethane compounds were formed, depending on the structure of the aminimide and on the concentration of the solutions.

  标题 N-氨基金酰胺（氨基亚胺）通过乳酸酯或α-羟基羧酸酯以良好的产率制备得到。通过在间甲苯中热分解这些氨基亚胺，可以形成某些类型的氨基甲酸酯化合物，这取决于氨基亚胺的结构和溶液的浓度。
• Indazole derivatives as JNK inhibitors and compositions and methods related thereto
  申请人：——

  公开号：US20020103229A1

  公开（公告）日：2002-08-01

  Compounds having activity as selective inhibitors of JNK are disclosed. The compounds of this invention are indazole derivatives having the following structure: 1 wherein R 1 , R 2 and A are as defined herein. Such compounds have utility in the treatment of a wide range of conditions that are responsive to JNK inhibition. Thus, methods of treating such conditions are also disclosed, as are pharmaceutical compositions containing one or more compounds of the above compounds.

  本发明公开了作为JNK选择性抑制剂的化合物。本发明的化合物是吲唑衍生物，具有以下结构： 1 其中R 1 ，R 2 和A如本文所述定义。此类化合物在治疗对JNK抑制产生响应的广泛病症方面具有用途。因此，还公开了治疗此类病症的方法，以及包含一个或多个上述化合物的药物组合物。
• [EN] AZOLE DERIVATIVES AS WTN PATHWAY INHIBITORS<br/>[FR] DÉRIVÉS D'AZOLE EN TANT QU'INHIBITEURS DE LA VOIE WNT
  申请人：OSLO UNIVERSITY HOSPITAL HF

  公开号：WO2010139966A1

  公开（公告）日：2010-12-09

  The present invention relates to new compounds of formula I, to processes for their preparation, to pharmaceutical formulations containing such compounds and to their use in therapy. Such compounds find particular use in the treatment and/or prevention of conditions or diseases which are affected by over-activation of signaling in the Wnt pathway. For example, these may be used in preventing and/or retarding proliferation of tumor cells, for example carcinomas such as colon carcinomas.

  本发明涉及公式I的新化合物，涉及其制备过程，含有这种化合物的药物配方以及它们在治疗中的应用。这些化合物在治疗和/或预防受到Wnt信号通路过度激活影响的疾病或病症中发挥特定作用。例如，它们可用于预防和/或延缓肿瘤细胞的增殖，例如结肠癌等癌症。
• Heterocycle syntheses by diaminocarbene—palladium(II) complex intermediates
  作者：Yoshihiko Ito、Toshikazu Hirao、Takeo Saegusa

  DOI：10.1016/s0022-328x(00)91364-0

  日期：1977.5

  with α-amino acid esters, with α-hydroxy acid hydrazides and with α-amino acid hydrazides, respectively. Diaminocarbene—palladium(II) complexes, which are involved as key intermediates in these heterocycle syntheses, were isolated and characterized. Diaminocarbene—palladium(II) complexes, which are prepared from PdCl2(t-C4H9NC)2 and β-aminoalcohols, such as methyl threonate and o-aminophenol, were reacted

  咪唑酮，二氢恶二嗪酮和四氢三嗪酮是通过PdCl 2催化的异腈与α-氨基酸酯，α-羟基酰肼和α-氨基酸酰肼反应而合成的。分离并表征了作为这些杂环合成中关键中间体的二氨基卡宾-钯（II）配合物。由PdCl 2（tC 4 H 9 NC）2和β-氨基醇（如苏糖酸甲酯和邻氨基苯酚）制得的二氨基碳烯-钯（II）配合物与Ag 2 O反应，得到（N-叔丁基亚氨基）恶唑烷。